ATE464911T1 - Zusammensetzungen zur behandlung von systemischer mastocytose - Google Patents

Zusammensetzungen zur behandlung von systemischer mastocytose

Info

Publication number: ATE464911T1
Authority: AT; Austria
Prior art keywords: systemic mastocytosis; compositions; mast cell; treating systemic; inhibitor
Prior art date: 2005-07-20

Application number

AT06764231T

Other languages

English (en)

Inventor

Peter Valent

Original Assignee

Peter Valent

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-20

Filing date

2006-07-19

Publication date

2010-05-15

2006-07-19 Application filed by Peter Valent filed Critical Peter Valent

2010-05-15 Application granted granted Critical

2010-05-15 Publication of ATE464911T1 publication Critical patent/ATE464911T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

AT06764231T 2005-07-20 2006-07-19 Zusammensetzungen zur behandlung von systemischer mastocytose ATE464911T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70109805P	2005-07-20	2005-07-20
PCT/EP2006/064431 WO2007010014A2 (en)	2005-07-20	2006-07-19	Compositions for treatment of systemic mastocytosis

Publications (1)

Publication Number	Publication Date
ATE464911T1 true ATE464911T1 (de)	2010-05-15

Family

ID=37669166

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06764231T ATE464911T1 (de)	2005-07-20	2006-07-19	Zusammensetzungen zur behandlung von systemischer mastocytose

Country Status (15)

Country	Link
US (1)	US8076321B2 (de)
EP (1)	EP1909837B8 (de)
JP (1)	JP5322639B2 (de)
KR (1)	KR101351682B1 (de)
CN (1)	CN101267837B (de)
AT (1)	ATE464911T1 (de)
AU (1)	AU2006271652B2 (de)
BR (1)	BRPI0613863A2 (de)
CA (1)	CA2615598C (de)
DE (1)	DE602006013826D1 (de)
ES (1)	ES2343542T3 (de)
PL (1)	PL1909837T3 (de)
PT (1)	PT1909837E (de)
RU (1)	RU2429848C2 (de)
WO (1)	WO2007010014A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2943418A1 (fr) *	2009-03-17	2010-09-24	Centre Nat Rech Scient	Procedes de mesure de la quantite intracellulaire de molecules d'interet intrinsequement fluorescentes par cytometrie en flux et leurs applications
PL244930B1 (pl) *	2021-12-08	2024-04-02	Gdanski Univ Medyczny	Zastosowanie 2-metoksyestradiolu w leczeniu mastocytozy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19857040C2 (de) *	1998-12-10	2000-12-21	Siemens Ag	Verfahren zur Detekton und Korrektur von Nichtlinearitäten hochfrequenter, spannungsgesteuerter Oszillatoren
US20030170720A1 (en) *	2001-01-23	2003-09-11	Van Der Kuyl Antoinette Cornelia	Means and methods for treatment evaluation
JP2005503361A (ja) *	2001-06-29	2005-02-03	アブサイエンス	肥満細胞症治療のための強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤の使用
TWI324604B (en) *	2003-06-18	2010-05-11	Novartis Ag	New use of staurosporine derivatives
CA2538523A1 (en) *	2003-09-19	2005-03-31	Novartis Ag	Treatment of gastrointestinal stromal tumors with imatinib and midostaurin
BRPI0416680A (pt) *	2003-11-18	2007-02-13	Novartis Ag	inibidores da forma mutante de kit
US8247419B2 (en)	2005-06-09	2012-08-21	Bristol-Myers Squibb Company	Methods of identifying and treating individuals exhibiting mutant kit protein

2006
- 2006-07-19 CN CN2006800341476A patent/CN101267837B/zh not_active Expired - Fee Related
- 2006-07-19 ES ES06764231T patent/ES2343542T3/es active Active
- 2006-07-19 AT AT06764231T patent/ATE464911T1/de active
- 2006-07-19 DE DE602006013826T patent/DE602006013826D1/de active Active
- 2006-07-19 US US11/996,081 patent/US8076321B2/en not_active Expired - Fee Related
- 2006-07-19 RU RU2008105823/15A patent/RU2429848C2/ru not_active IP Right Cessation
- 2006-07-19 EP EP06764231A patent/EP1909837B8/de not_active Not-in-force
- 2006-07-19 BR BRPI0613863-2A patent/BRPI0613863A2/pt not_active IP Right Cessation
- 2006-07-19 PT PT06764231T patent/PT1909837E/pt unknown
- 2006-07-19 PL PL06764231T patent/PL1909837T3/pl unknown
- 2006-07-19 JP JP2008521973A patent/JP5322639B2/ja not_active Expired - Fee Related
- 2006-07-19 AU AU2006271652A patent/AU2006271652B2/en not_active Ceased
- 2006-07-19 KR KR1020087003987A patent/KR101351682B1/ko not_active IP Right Cessation
- 2006-07-19 CA CA2615598A patent/CA2615598C/en not_active Expired - Fee Related
- 2006-07-19 WO PCT/EP2006/064431 patent/WO2007010014A2/en active Application Filing

Also Published As

Publication number	Publication date
CN101267837B (zh)	2010-12-15
KR20080039915A (ko)	2008-05-07
CN101267837A (zh)	2008-09-17
AU2006271652A1 (en)	2007-01-25
WO2007010014A2 (en)	2007-01-25
CA2615598C (en)	2014-04-15
ES2343542T3 (es)	2010-08-03
AU2006271652B2 (en)	2010-04-29
EP1909837B1 (de)	2010-04-21
KR101351682B1 (ko)	2014-01-14
US20090221550A1 (en)	2009-09-03
EP1909837A2 (de)	2008-04-16
BRPI0613863A2 (pt)	2011-02-15
PT1909837E (pt)	2010-07-07
WO2007010014A3 (en)	2007-06-14
JP5322639B2 (ja)	2013-10-23
DE602006013826D1 (de)	2010-06-02
RU2008105823A (ru)	2009-08-27
JP2009501767A (ja)	2009-01-22
US8076321B2 (en)	2011-12-13
CA2615598A1 (en)	2007-01-25
EP1909837B8 (de)	2010-06-02
RU2429848C2 (ru)	2011-09-27
PL1909837T3 (pl)	2010-09-30

Similar Documents

Publication	Publication Date	Title
NO20081636L (no)	2008-05-29	FAP - inhibitorer
EA201100426A1 (ru)	2011-10-31	Бициклические ингибиторы киназы
EA201000089A1 (ru)	2010-06-30	Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
MY163477A (en)	2017-09-15	Pyrimidinyl-pyridazinone derivatives
ATE456571T1 (de)	2010-02-15	Proteasom-hemmer und verwendungsverfahren dafür
UA109878C2 (uk)	2015-10-26	Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти)
NO20060398L (no)	2006-02-28	Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft
EA200870019A1 (ru)	2008-12-30	Лактамовые соединения и способы их применения
DK1660507T3 (da)	2009-11-02	Proteasominibitorer og metoder til anvendelse heraf
NI200800060A (es)	2009-03-03	Bencimidazoles sustituidos como inhibidores de cinasa.
ATE516286T1 (de)	2011-07-15	5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes
DE602005023763D1 (de)	2010-11-04	Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
TW200722421A (en)	2007-06-16	Azole derivatives as inhibitors of lipases and phospholipases
EA201170288A1 (ru)	2011-12-30	Оксабициклогептаны и оксабициклогептены, их получение и применение
ATE470443T1 (de)	2010-06-15	Indol-1-yl-essigsäurederivate
EA200800014A1 (ru)	2008-06-30	Аминохинолиновые и аминохиназолиновые модуляторы киназы
DE502005002697D1 (de)	2008-03-13	Als kinaseinhibitoren geeignete derivate des n,n'-diphenylharnstoffs
DK1948155T3 (da)	2012-07-02	Farmaceutiske præparater omfattende droxidopa
EA201001648A1 (ru)	2011-06-30	Производные пиридазинона
DE602005012069D1 (de)	2009-02-12	Inhibitoren von mitotischem kinesin
ATE555108T1 (de)	2012-05-15	Polyamide zur behandlung des menschlichen papilloma-virus
ATE502935T1 (de)	2011-04-15	C-met-proteinkinasehemmer
DE60329326D1 (de)	2009-10-29	Tace inhibitoren
ATE464911T1 (de)	2010-05-15	Zusammensetzungen zur behandlung von systemischer mastocytose
NO20065471L (no)	2007-01-09	Anvendelse av IL-6 for behandling eller forebygging av kjemoterapiindusert nevropati.

Legal Events

Date

Code

Title

Description

2010-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1909837

Country of ref document: EP